未登录

G

Gabriela Senti

university zurich hospital

H指数:35

被引数:4,286

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans

FRONTIERS IN ALLERGY

IF3.1

2022-03-165

OAAI

Immunization of Cats against Fel d 1 Results in Reduced Allergic Symptoms of Owners

IF3.5

2020-03-0625

OAAI

Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2019-07-0157

OAAI

Letter to the Editor: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2019-01-152

PREAI

Allergen immunotherapy in allergic rhinitis: current use and future trends

过敏性鼻炎的过敏原免疫治疗: 当前使用和未来趋势

EXPERT REVIEW OF CLINICAL IMMUNOLOGY

IF3.7

2017-06-1535

PREAI

A bizarre attack on the freedom of scientific expression

IF12

2015-08-270

PREAI

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials

IF12

2015-03-1379

OAAI

Intralymphatic immunotherapy

WORLD ALLERGY ORGANIZATION JOURNAL

IF4.3

2015-01-0137

OAAI

New routes for allergen immunotherapy

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2014-10-2734

OAAI

Comparing safety of abrasion and tape-stripping as skin preparation in allergen-specific epicutaneous immunotherapy

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2014-10-0136

OAAI

Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine

IF12

2014-07-1249

PREAI

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs

EXPERT REVIEW OF CLINICAL IMMUNOLOGY

IF3.7

2014-06-0522

PREAI

Intralymphatic immunotherapy: Time interval between injections is essential

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2014-03-0140

PREAI

IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization

IF12

2013-12-1954

PREAI

A Randomized, Double-Blind, Placebo-Controlled Study to Test the Efficacy of Topical 2-Hydroxypropyl-Beta-Cyclodextrin in the Prophylaxis of Recurrent Herpes Labialis

IF2.7

2013-06-2510

OAAI

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2012-05-01236

OA

The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy

IF12

2012-03-0215

PREAI

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2012-01-01133

OAAI

Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2011-10-17173

OAAI

Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?

IF12

2011-02-2455

OAAI